Drug Profile
Streptococcal A vaccine - SIGA
Alternative Names: StrepImmuneLatest Information Update: 23 Sep 2014
Price :
$50
*
At a glance
- Originator SIGA Technologies
- Class Streptococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Streptococcal infections
Most Recent Events
- 16 Aug 2002 This vaccine is still in active development
- 29 Dec 2000 Phase-I clinical trials in Streptococcal infections in USA (unspecified route)
- 15 Oct 1999 SIGA has been awarded a SBIR grant for development of the vaccine